Changes in Hip Fracture Rates in Southeastern Australia Spanning the Period 1994-2007

Julie A Pasco; Sharon L Brennan; Margaret J Henry; Geoffrey C Nicholson; Kerrie M Sanders; Yu Zhang; Mark A Kotowicz

Journal article

Changes in Hip Fracture Rates in Southeastern Australia Spanning the Period 1994-2007

Julie A Pasco, Sharon L Brennan, Margaret J Henry, Geoffrey C Nicholson, Kerrie M Sanders, Yu Zhang, Mark A Kotowicz

JOURNAL OF BONE AND MINERAL RESEARCH | WILEY | Published : 2011

DOI: 10.1002/jbmr.393

Abstract

Hip fracture incidence rates appear to be declining in Western populations. Utilizing comprehensive incident hip fracture data from radiology reports, we determined changes in hip fracture rates in southeastern Australia between 1994-1996 and 2006-2007 for residents aged 55 years or older. During this period, the population at risk increased by 47% for men and 40% for women. Although the absolute number of hip fractures increased by 53% in men and 4.4% in women, standardized hip fracture ratios were 0.92 [95% confidence interval (CI) 0.79-1.08] and 0.69 (95% CI 0.62-0.77), respectively. Marked reductions in hip fracture rates were observed for women: 32% for ages 75 to 84 years and 29% for a..

View full abstract

University of Melbourne Researchers

Mark Kotowicz Author

Kerrie Sanders Author

Julie Pasco Author

Sharon Brennan-Olsen Author

Related Projects (2)

Male osteoporosis: a population based study in geelong

Osteoporosis is a term used to indicate that bones have become thin and fragile. During the ageing process bone fragility increases and frac..

Bone size and bone turnover: relationship to fracture risk over ten years

The occurrence of fracture in the ageing population is a major public health problem because these fractures are responsible for considerabl..

Grants

Awarded by NHMRC

Funding Acknowledgements

JAP was a recipient of the grants from the NHMRC (projects 251638, 299831, and 628582), Geelong Regional Medical Research Foundation, Arthritis Foundation of Australia and Amgen (Europe) GmBH. SLB was supported by an NHMRC scholarship (519404, 2010) and an NHMRC postdoctoral (training) fellowship (1012472, 2011). MJH was a recipient of the grants from the NHMRC (project 628582) and Amgen (Europe) GmBH. GCN was a recipient of the grants from the NHMRC (projects 251638, 299831, and 628582) and Amgen (Europe) GmBH. MAK was a recipient of grants from the NHMRC (projects 251638, 299831, and628582), Geelong Regional Medical Research Foundation, and Amgen (Europe) GmBH. All the other authors state that they have no conflicts of interest.The study was supported by the NHMRC (Project Nos. 251638, 299831, and 628582), the Victorian Health Promotion Foundation, the Geelong Regional Medical Foundation, the Arthritis Foundation of Australia, and Amgen (Europe) GmBH, but they played no part in the design or conduct of the study; collection, management, analysis, and interpretation of the data; or preparation or review of the manuscript.